← Eichor
Study identifier: NCT05589974 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy

Condition: Central Serous Chorioretinopathy  ·  Sponsor: Helse Stavanger HF

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

Patients with central serous chorioretinopathy (CSC) will be monitored with laser speckle flow graphy (LSFG), swept source optical coherence tomography (SS-OCT) and SS-OCT angiography (SS-OCTA). The aim is to unveil the flow and pulse wave characteristics of the choroidal circulation in acute CSC and chronic CSC.

This description comes directly from the study's public registry record.

Talk to the study team

Vegard Forsaa, MD PhD  ·  +4748152212  ·  forsaa@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Stavanger University Hospital, Department of OphthalmologyStavanger, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05589974